Physician

Arthur Michael Brant, M.D. PH.D.

According to 2025 Medicare claims, Arthur Brant, M.D. PH.D. (NPI: 1710990445) practices ophthalmology in the Pittsburgh, PA market, with the plurality of this provider's patient population coming from Beaver, PA. Brant uses personal NPI as billing NPI and primary practice location at 15009-1724.

Brant's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 398 traditional Medicare patients, billed 6,223 HCPCS/CPT codes, and received $415,171 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 805 prescription claims across 182 beneficiaries totaling $34,257 in drug costs, led by Tobradex (Tobramycin/Dexamethasone). Open Payments data shows 2 records totaling $125. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $34,629 and ending at $34,257. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$227K$454K2015 Medicare payment: $388,072 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $454,065 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $388,204 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $349,745 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $409,771 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $383,916 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $429,610 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $423,171 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $413,753 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $415,171 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153835,241$388,072
20163704,949$454,065
20173564,435$388,204
20183353,912$349,745
20193654,378$409,771
20203023,793$383,916
20213664,425$429,610
20223954,783$423,171
20233985,363$413,753
20243986,223$415,171

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$26K$51K2015 Drug cost: $34,629 (USD; Tot_Drug_Cst)2016 Drug cost: $31,944 (USD; Tot_Drug_Cst)2017 Drug cost: $24,988 (USD; Tot_Drug_Cst)2018 Drug cost: $24,221 (USD; Tot_Drug_Cst)2019 Drug cost: $31,480 (USD; Tot_Drug_Cst)2020 Drug cost: $32,325 (USD; Tot_Drug_Cst)2021 Drug cost: $46,379 (USD; Tot_Drug_Cst)2022 Drug cost: $39,814 (USD; Tot_Drug_Cst)2023 Drug cost: $51,303 (USD; Tot_Drug_Cst)2024 Drug cost: $34,257 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015330991$34,629
2016317922$31,944
2017140633$24,988
2018140578$24,221
2019184764$31,480
2020143639$32,325
2021182898$46,379
2022198794$39,814
2023208933$51,303
2024182805$34,257

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92235Exam of retinal blood vessels using a special camera after injection of a dye170202$124
67028Injection of drug into eye1581,085$86
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more280349$61
92134Imaging of retina167876$29
92250Photography of the retina370568$25

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
TobradexTobramycin/Dexamethasone38457$9,846
Ketorolac TromethamineKetorolac Tromethamine2897,701$9,267
Tobramycin-DexamethasoneTobramycin/Dexamethasone681,598$2,631
Brimonidine TartrateBrimonidine Tartrate26688$2,432
Prednisolone AcetatePrednisolone Acetate531,241$1,769

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$125Regeneron Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Arthur Michael Brant, M.D. PH.D.?

Tedicare shows public-source Medicare data for Arthur Michael Brant, M.D. PH.D. (NPI 1710990445), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Arthur Michael Brant, M.D. PH.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Arthur Michael Brant, M.D. PH.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Arthur Michael Brant, M.D. PH.D. have Open Payments data?

Arthur Michael Brant, M.D. PH.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.